Parallel Advisors »

Inozyme Pharma shares owned by Parallel Advisors

Quarter-by-quarter ownership of Inozyme Pharma (INZY) shares owned by Parallel Advisors from 13F filings

Historical chart of Parallel Advisors investment in Inozyme Pharma

Tip: Access up to 7 years of quarterly data

All positions including Inozyme Pharma held by Parallel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inozyme Pharma by Parallel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $68k 16k 4.26
2023-09-30 $66k 16k 4.20
2023-06-30 $86k 15k 5.57
2023-03-31 $114k 20k 5.73
2022-12-31 $21k 20k 1.05

More positions owned by Parallel Advisors

Ishares Core S&p Total U.s. Stock Market Etf Etf (ITOT)
Ishares S&p 500 Index Etf (IVV)
Apple Stock (AAPL)
Corcept Therapeutics Stock (CORT)
Ishares Msci Usa Quality Factor Etf Etf (QUAL)
Microsoft Stock (MSFT)
Cvb Finl Corp Stock (CVBF)
Nvidia Corp Stock (NVDA)
Ishares Core Msci Eafe Etf Etf (IEFA)
Vanguard Large Cap Etf (VV)
Amazon.com Stock (AMZN)
Ishares Tr Lehman Short Trea Bd Etf (SHV)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Ishares Aggregate Bond Etf Etf (AGG)
Vanguard Small Cap Etf Etf (VB)

View all positions for Parallel Advisors

Top funds holding Inozyme Pharma

Samlyn Capital
Eventide Asset Management
NEA Management Company
Vanguard Group
Sphera Funds Management
Samsara BioCapital
Blue Owl Capital Holdings
Millennium Management
Laurion Capital Management
Octagon Capital Advisors
Goldman Sachs Group
Kennedy Capital Management
Overbrook Management Corp.
Citadel Advisors
GSA Capital Partners

View all funds holding Inozyme Pharma